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CORRESPONDENCE
The Author Response
Presence of Evolutionary Pressures or Genotyping Error
Kyung Tae
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University, Seoul, Korea
I would like to thank the interest and comments to our paper 
entitled “XRCC1 polymorphisms and risk of papillary thyroid 
carcinoma in a Korean sample” (1). In our study, we genotyped 
XRCC1 Arg194Trp and Arg399Gln single nucleotide polymor-
phisms (SNPs) in 111 papillary thyroid carcinoma patients and 
100 normal control subjects. In the results of our study, the XRCC1 
Arg194Trp Arg/Trp genotype was significantly associated with 
a decreased risk of papillary thyroid carcinoma compared to that 
of Arg/Arg genotype, while the XRCC1 Arg399Gln genotype was 
not associated with a risk of papillary thyroid carcinoma. 
  I agree with the comments. There was a mistake in the calcu-
lation of Hardy-Weinberg equilibrium (HWE). A genotype dis-
tribution of XRCC1 Arg194Trp was in HWE (control P = 0.728, 
case P = 0.768); however, a genotype distribution of XRCC1     
Arg399Gln deviated from HWE (control P = 0.0002, case P =  
0.0003). The deviation from HWE could be associated with the 
sampling bias or the presence of evolutionary pressure, and it 
might be also associated with the genotyping error. As I already 
mentioned some limitations of our study in the paper, there 
was a selection bias as a hospital-based case-control study. The 
control group in our study may not have accurately represented 
the general population, and the genotype distribution of XRCC1 
Arg399Gln deviated from HWE. Also, our study included a rela-
tively small number of cases and controls. Therefore, the results 
of our study should be interpreted with caution. A further study 
with using large, matched case-control samples is necessary to 
validate the genetic effects of XRCC1 polymorphisms in the Ko-
rean population.    
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